MedTrace Logo

A Study to Assess the Effect of Psyllium vs. Wheat Dextrin on Glycemic Control and Inflammatory Markets in Diabetes Mellitus 2

NCT04547790 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 101

Last updated 2024-03-28

No results posted yet for this study

Summary

The purpose of this study is to determine which of Psyllium and Wheat Dextrin is more effective in lowering fasting blood sugar and hemoglobin A1c, and to evaluate the effects they have on laboratory values.

Conditions

  • Type2 Diabetes

Interventions

DIETARY_SUPPLEMENT

Psyllium

One level scoop (12.5mL) of 5.1g of psyllium fiber twice a day with 8 ounces water

DIETARY_SUPPLEMENT

Wheat Dextrin

One level scoop (12.5 mL) of 1.7g wheat dextrin fiber twice a day with 8 ounces water

Sponsors & Collaborators

Principal Investigators

  • Stephen Kopecky, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-23
Primary Completion
2023-11-27
Completion
2023-11-27

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04547790 on ClinicalTrials.gov